|
CapitalBio Corporation
custom microrna microarray panel ![]() Custom Microrna Microarray Panel, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/custom microrna microarray panel/product/CapitalBio Corporation Average 90 stars, based on 1 article reviews
custom microrna microarray panel - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: PLoS ONE
Article Title: A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy
doi: 10.1371/journal.pone.0091388
Figure Lengend Snippet: Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the training data set (42 SCLC patients).
Article Snippet: Hybridization was performed using a
Techniques: Control
Journal: PLoS ONE
Article Title: A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy
doi: 10.1371/journal.pone.0091388
Figure Lengend Snippet: (C) Correlation between expression of U6 RNA by qRT-PCR and log 2-transformed global mean array expression. (D) Expression of U6 RNA in human normal lung (NL, n = 3) and small-cell lung cancer (SCLC, n = 42) samples by microarray method. Whiskers depict the 10 and 90 percentiles. p value is calculated by the Mann-Whitney U test.
Article Snippet: Hybridization was performed using a
Techniques: Expressing, Quantitative RT-PCR, Transformation Assay, Microarray, MANN-WHITNEY
Journal: PLoS ONE
Article Title: A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy
doi: 10.1371/journal.pone.0091388
Figure Lengend Snippet: Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasisfree survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the testing data set (40 SCLC patients).
Article Snippet: Hybridization was performed using a
Techniques: Control